Adverse Events Following COVID-19 Vaccination among the Beneficiaries of Sikkim Manipal University: A Cross Sectional Study


  • Jayden Lhamu Bhutia Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Binu Upreti Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Eden Jamyang Bhutia Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Sumit Kar Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Forhad Akhtar Zaman All India Institute of Medical Sciences, Guwahati



Covid-19 Vaccine, Covishield, Adverse Events, AEFI, Side Effects


Background: Covid-19, an infection caused by SARS- CoV2 has claimed millions of lives since late 2019 with no curative measures. In India, 4 vaccines have been approved for use i.e. Serum Institute’s Covishield, Bharat Biotech’s Covaxin, GRIEM’s Sputnik V and Moderna’s Covid-19 vaccine. Aims: This study aims to find the adverse events following Covishield vaccination among the beneficiaries of Sikkim Manipal University, Sikkim. Material &Methods: A cross sectional study was conducted among the beneficiaries of Sikkim Manipal University to find out the adverse events following the first dose of vaccination. The data was collected using a self-administered questionnaire when the beneficiaries came for their second dose of vaccination. Microsoft Excel and SPSS version 27 was used for statistical analysis. Results: Out of 716 study participants majority i.e. 79.5% of the study participants developed adverse events following their first dose with maximum (73.8%) complaining of pain at the site of infection followed by fever (65.2%). Conclusions: Vaccines may prevent diseases, but it also brings about adverse effects, be it minor or major. Hence, many studies are required to study their full-fledged side effects and the means to overcome them.


Download data is not yet available.


World Health Organization. 2019-nCoV outbreak is an emergency of international concern[Internet]. 2020 (Accessed on 28/12/2021). Available from:

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases.2020;20(5):533-4.

Jones L,PalumboD,BrownD.Coronavirus: How the pandemic has changed the world economy[Internet].2021.BBC(Accessed on 28/12/2021).Available from :

Vuj?i? I, Safiye T, Miliki? B, Popovi? E, Dubljanin D, Dubljanin E, Dubljanin J, ?abarkapa M. Coronavirus Disease 2019 (COVID-19) Epidemic and Mental Health Status in the General Adult Population of Serbia: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2021;18(4):1957.

Batra K, Sharma M, Batra R, Singh TP, Schvaneveldt N. Assessing the psychological impact of COVID-19 among college students: an evidence of 15 countries. InHealthcare 2021;9(2):222). Multidisciplinary Digital Publishing Institute.

Pinghui Z. Coronavirus: WHO backed China’s emergency use of experimental vaccines, health official says [Internet].South China Morning Post. Accessed on 28/12/2021. Available from :

Kramer A E. Russia Is Slow to Administer Virus Vaccine Despite Kremlin’s Approval[Internet].The New York Times.Published Sept. 19, 2020.Updated Nov. 24, 2020. Accessed on 28/12/2021. Available from :

MHRA. Information for healthcare professionals on Pfizer-BioNTech Covid-19 vaccine [Internet].Updated 2021 Jan 28.Accessed on 28/12/2021. Available from :

Bahrain News Agency. Bahrain second in the world to approve the Pfizer/BioNTech Covid-19 vaccine [Internet].2020. Updated on 2021 Mar 8. Accessed on 28/12/2021. Available from:

Oliver SE. The advisory committee on immunization practices’ interim recommendation for use of moderna COVID-19 vaccine—United States, 2020. MMWR. Morbidity and mortality weekly report. 2021;69.Available from :

ICMR.Covid-19 vaccines.[Internet].Accessed on 28/12/2021.Available from:

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021; 397(10269):99–111.

Ministry Of Health and Family Welfare.FAQs on Covid-19 vaccines[Internet).Accessed on 28/12/2021. Available from :

Ritchie H, Ortiz-Ospina E, BeltekianD,MathieuE,HasellJ,MacdonaldB,et al. (2020) - "Coronavirus Pandemic (COVID-19)". Published online at [Internet).Accessed on28/12/2021. Available from:

Pottegård A, Lund L C, Karlstad O, Dahl J, Andersen M, Hallas J,et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZenecaChAdOx1-S in Denmark and Norway: population based cohort study.BMJ 2021;373:n1114

Jeon M, Kim J, Oh CE, Lee J-Y. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System. J Korean Med Sci. 2021;36(17):e114.

EU countries suspend use of Covid-19 vaccine Astra Zeneca [Internet).UpdatedMarch 2021. Accessed on 28/12/2021. Available from:

Kaushal SK, Patel AK, Yadav M, Kumar N. Assessment of adverse event following immunization and its co-relates among COVID-19 vaccine recipient in Bundelkhand region of Uttar Pradesh: A cross-sectional study. Indian J Comm Health. 2021;33(2):379-382.

CoWin. AEFI report.[Internet].Accessed on 28/12/2021. Available from




How to Cite

Bhutia JL, Upreti B, Bhutia EJ, Kar S, Zaman FA. Adverse Events Following COVID-19 Vaccination among the Beneficiaries of Sikkim Manipal University: A Cross Sectional Study. Indian J Community Health [Internet]. 2021 Dec. 31 [cited 2024 Jul. 25];33(4):603-7. Available from:



Original Article